Best Chemotherapy for breast cancer Doctors in Istanbul for Australians

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Professor Eda Tanrikulu is a top-tier medical oncologist who ranked third nationwide in the Turkish minor specialty exam for her field.

• Specialises in matching targeted therapies to the unique genetic profile of breast tumours
• Leads international clinical trials at Anadolu Medical Center – an institution affiliated with Johns Hopkins Medicine
• Former Head of Medical Oncology at Haydarpaşa Numune Training and Research Hospital
• Holds active memberships in the American Society of Medical Oncology and ESMO

Associate Professor Mustafa Solak gained vital experience at the MD Anderson Cancer Center in the US – the top-ranked cancer hospital globally.

• Performed over 1,100 successful treatments for complex solid tumours
• Completed an advanced oncology fellowship at the Hacettepe University Cancer Institute
• Specialises in evidence-based protocols using modern immunotherapy and targeted therapies
• Manages systemic treatments for breast cancer at Hisar Hospital Intercontinental

Professor Sezer Sağlam leads the Medical Oncology Department at Gayrettepe Florence Nightingale Hospital, where he applies European-standard protocols for breast cancer treatment.

• Maintains active membership in the American Society of Clinical Oncology (ASCO)
• Fellowship trained at Istanbul University – a leading Turkish academic medical centre
• Collaborates with the European Neuroendocrine Tumour Society to stay updated on complex cases
• Specialises in internal medicine and medical oncology with a focus on targeted drug therapies
• Holds full professorship status, signifying the highest level of clinical and academic seniority

Associate Professor Emine Yildirim is a leading specialist in neoadjuvant chemotherapy protocols, focusing on shrinking tumours before breast-conserving surgery.

• Published extensive research on pathological response rates in axillary and breast tissue following chemotherapy
• Holds international certificates in triple-negative and HER2-positive breast cancer management
• Specialises in precise surgical margin assessment and nipple-sparing techniques
• Evaluates chemotherapy effectiveness using advanced MRI and ultrasonography imaging

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Professor Yesim Yildirim is an ESMO-certified medical oncologist at Anadolu Medical Center with over 80 scientific publications. She completed specialist training at Mount Vernon Cancer Center in the UK and Rambam Medical Center in Israel.

• Specialises in targeted therapies and immunotherapy for breast cancer cases
• Recognised by the European Society of Medical Oncology via professional certification
• Founder of the Turkish Gastrointestinal Oncology Network
• Completed an MBA in Healthcare Management to lead clinical teams
• Member of the American Society of Clinical Oncology

Professor Sezer Saglam is a leading academic and medical oncologist at Istanbul Florence Nightingale Hospital with senior expertise in managing complex tumour cases.

• Holds a professorship in medical oncology – the highest academic rank in Turkish medicine
• Completed a specialised fellowship at Istanbul University Oncology Institute
• Active member of the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Specialised training in gastrointestinal and neuroendocrine tumours provides a broad perspective on complex cancer care

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Associate Professor Tahsin Ozatli has managed over 1,100 oncology treatments at Istinye University Liv Hospital, specialising in targeted drug therapies for breast cancer.

• Promoted to Associate Professor in recognition of his clinical expertise
• Trained at the dedicated Ankara Oncology Clinic, Turkey's first specialised cancer centre
• Handled complex cases at Erzurum Regional Training and Research Hospital
• Focuses on systemic treatments for breast, lung, and gastrointestinal cancers
• Coordinates multidisciplinary care plans with radiation oncologists and surgeons

Professor Cemil Bilir is a highly qualified medical oncologist at VM Medical Park Pendik who is currently pursuing a PhD in inorganic chemistry to deepen his expertise in treatment formulations.

• Completed a research fellowship at Northeastern University's Center for Pharmaceutical Biotechnology and Nanomedicine in Boston
• Published extensive research on medical oncology during his tenure as a Professor at Sakarya University
• Gained international clinical experience through a rotation at the world-leading Cleveland Clinic
• Holds active memberships in the European Society for Medical Oncology and the American Society of Clinical Oncology

Professor Irfan Cicin is a senior medical oncologist who leads cancer care at İstinye University Liv Hospital Topkapı. He holds a professorship at Trakya University, where he trains the next generation of cancer specialists.

• Completed specialist oncology fellowship at Trakya University Faculty of Medicine
• Experienced in managing complex internal medicine cases alongside chemotherapy
• Served as a physician for the Turkish Air Force Command
• Former lead oncologist at Elazığ Training and Research Hospital
• Expertise covers a broad range of hard-to-treat solid tumours

Professor Ercan Ozden is a specialist in medical oncology who completed his advanced subspecialty training at the Kocaeli University Faculty of Medicine.

• Specialised in medical oncology and internal medicine at Istanbul University's renowned Cerrahpaşa Faculty
• Practises at VM Medical Park Pendik Hospital – a major multidisciplinary medical centre
• Focuses on tailoring chemotherapy protocols for breast cancer patients
• Member of the Turkish Society of Medical Oncology

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital Topkapı, specialising in tailormade chemotherapy protocols for complex breast cancer cases.

• Expert in managing high-risk breast cancer based on BRCA genetic mutation profiles
• Specialises in adjuvant capecitabine therapy for patients with residual triple-negative breast cancer
• Published researcher on the impact of metabolic tumour volume on chemotherapy response
• Active member of the American Society of Clinical Oncology (ASCO)
• Education Coordinator for Medical Oncology at one of Turkey's major training hospitals

Professor Ahmet Bilici leads the oncology department at Medipol Mega University Hospital, where he applies evidence-based drug protocols for complex breast cancer cases.

• Specialises in medical oncology with a focus on chemo-sensitive tumours
• Oversees treatment at a JCI-accredited university centre in Turkey
• Active researcher in clinical oncology with numerous international publications
• Member of the European Society for Medical Oncology (ESMO)
• Focuses on balancing rigorous treatment with patient quality of life

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acibadem District Hospital, specialising in neoadjuvant chemotherapy and targeted therapies for breast cancer.

• Published over 50 scientific articles focusing on treatment responses and patient prognosis
• Expert in managing cancer-related malnutrition and cachexia to support patients during intensive chemotherapy
• Serves on the editorial board of BMC Cancer, a major international medical journal
• Member of the European Society for Medical Oncology (ESMO)
• Completed a clinical observership at the University of Leicester in the United Kingdom

Associate Professor Ayse Irem Yasin is a highly qualified medical oncologist who completed a targeted international observership at Italy's Maggiore della Carita Hospital Breast Cancer Unit.

• Holds a European Society for Medical Oncology (ESMO) Board Certification
• Gained specialist clinical experience at Cleveland Clinic and Harvard Medical School
• Specialises in managing complex systemic therapies for breast and gynaecological cancers
• Academically recognised as an Associate Professor for her contributions to oncology
• Practises at Medipol Acibadem District Hospital in Istanbul

Associate Professor Nail Paksoy is a Board Certified medical oncologist who has served as a sub-investigator on high-profile international clinical trials for Roche and AstraZeneca.

• Specialises in chemotherapy for HER2-positive and BRCA-mutated breast cancers
• Holds European Society for Medical Oncology (ESMO) Board Certification
• Expert in treating metastatic cases and managing late-stage disease recurrence
• Extensively published in journals like Scientific Reports on long-term breast cancer outcomes
• Member of the Turkish Oncology Group with deep expertise in targeted drug therapies